Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Innovation1 Biotech's share price for the quarter that ended in Feb. 2024 was $0.022. Innovation1 Biotech's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 22.47 Mil. Therefore, Innovation1 Biotech's market cap for the quarter that ended in Feb. 2024 was $0.49 Mil.
Innovation1 Biotech's quarterly market cap
declined
from Aug. 2023 ($17.40 Mil) to Nov. 2023 ($0.35 Mil) but then
increased
from Nov. 2023 ($0.35 Mil) to Feb. 2024 ($0.49 Mil).
Innovation1 Biotech's annual market cap
increased
from Aug. 2021 ($0.57 Mil) to Aug. 2022 ($3.08 Mil) and
increased
from Aug. 2022 ($3.08 Mil) to Aug. 2023 ($17.40 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Innovation1 Biotech's Enterprise Value for Today is $0.51 Mil.
Innovation1 Biotech (OTCPK:IVBT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Innovation1 Biotech Market Cap Related Terms
Innovation1 Biotech Market Cap Historical Data
* Premium members only.
The historical data trend for Innovation1 Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Shell Companies subindustry, Innovation1 Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovation1 Biotech Market Cap vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Innovation1 Biotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Innovation1 Biotech's Market Cap for the fiscal year that ended in Aug. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovation1 Biotech (IVBT) has a Market Cap of $0.00 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's Market Cap too high?
Innovation1 Biotech's current Market Cap is $0.00 Mil. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Market Cap compare to NVIV and PXMD?
Innovation1 Biotech's Market Cap of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. The industry median Market Cap is 84.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Diversified Financial Services company?
The median Market Cap among Diversified Financial Services companies is 84.50, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Innovation1 Biotech and its competitors. For the Diversified Financial Services industry, the median Market Cap is 84.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovation1 Biotech's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Market Cap is $0.00 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVBT has been successfully added to your 
